Research Programme

The Translational & Respiratory Immunology (TRI) group aims to design novel treatments for chronic and acute respiratory conditions. By harnessing the unique properties of microbial-derived compounds and metabolites we aim to modulate the lungs immune system. Our research programme is focused on a coherent and integrative approach at the intersection of basic and clinical research to enable innovative, simple and cost-effective therapies for respiratory care.

The research group is led by Dr Natalia Muñoz-Wolf, a research assistant professor in the School of Medicine at TCD.

ResearchGate | Google Scholar